<!DOCTYPE html>
<html lang="en"><head><title>08_Schmid_2001_Nature</title><meta charset="utf-8"/><link rel="preconnect" href="https://fonts.googleapis.com"/><link rel="preconnect" href="https://fonts.gstatic.com"/><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Schibsted Grotesk:wght@400;700&amp;family=Source Sans Pro:ital,wght@0,400;0,600;1,400;1,600&amp;family=IBM Plex Mono:wght@400;600&amp;display=swap"/><link rel="preconnect" href="https://cdnjs.cloudflare.com" crossorigin="anonymous"/><meta name="viewport" content="width=device-width, initial-scale=1.0"/><meta name="og:site_name" content="Web Of Biocatalysis"/><meta property="og:title" content="08_Schmid_2001_Nature"/><meta property="og:type" content="website"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:title" content="08_Schmid_2001_Nature"/><meta name="twitter:description" content="Industrial biocatalysis today and tomorrow (Schmid, Dordick, Hauer, Kiener, Wubbolts, Witholt, Nature 2001) Citation &amp; scope Industry-focused snapshot of what was already working at scale (BASF, DSM, Lonza) and a pragmatic framework—“the biocatalysis cycle” (from biocatalyst selection → process ..."/><meta property="og:description" content="Industrial biocatalysis today and tomorrow (Schmid, Dordick, Hauer, Kiener, Wubbolts, Witholt, Nature 2001) Citation &amp; scope Industry-focused snapshot of what was already working at scale (BASF, DSM, Lonza) and a pragmatic framework—“the biocatalysis cycle” (from biocatalyst selection → process ..."/><meta property="og:image:alt" content="Industrial biocatalysis today and tomorrow (Schmid, Dordick, Hauer, Kiener, Wubbolts, Witholt, Nature 2001) Citation &amp; scope Industry-focused snapshot of what was already working at scale (BASF, DSM, Lonza) and a pragmatic framework—“the biocatalysis cycle” (from biocatalyst selection → process ..."/><meta property="twitter:domain" content="glecko.xyz"/><meta property="og:url" content="https://glecko.xyz/backbone/core_reviews/summary/08_Schmid_2001_Nature"/><meta property="twitter:url" content="https://glecko.xyz/backbone/core_reviews/summary/08_Schmid_2001_Nature"/><link rel="icon" href="../../../static/icon.png"/><meta name="description" content="Industrial biocatalysis today and tomorrow (Schmid, Dordick, Hauer, Kiener, Wubbolts, Witholt, Nature 2001) Citation &amp; scope Industry-focused snapshot of what was already working at scale (BASF, DSM, Lonza) and a pragmatic framework—“the biocatalysis cycle” (from biocatalyst selection → process ..."/><meta name="generator" content="Quartz"/><link href="../../../index.css" rel="stylesheet" type="text/css" spa-preserve/><style>.expand-button {
  position: absolute;
  display: flex;
  float: right;
  padding: 0.4rem;
  margin: 0.3rem;
  right: 0;
  color: var(--gray);
  border-color: var(--dark);
  background-color: var(--light);
  border: 1px solid;
  border-radius: 5px;
  opacity: 0;
  transition: 0.2s;
}
.expand-button > svg {
  fill: var(--light);
  filter: contrast(0.3);
}
.expand-button:hover {
  cursor: pointer;
  border-color: var(--secondary);
}
.expand-button:focus {
  outline: 0;
}

pre:hover > .expand-button {
  opacity: 1;
  transition: 0.2s;
}

#mermaid-container {
  position: fixed;
  contain: layout;
  z-index: 999;
  left: 0;
  top: 0;
  width: 100vw;
  height: 100vh;
  overflow: hidden;
  display: none;
  backdrop-filter: blur(4px);
  background: rgba(0, 0, 0, 0.5);
}
#mermaid-container.active {
  display: inline-block;
}
#mermaid-container > #mermaid-space {
  border: 1px solid var(--lightgray);
  background-color: var(--light);
  border-radius: 5px;
  position: fixed;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  height: 80vh;
  width: 80vw;
  overflow: hidden;
}
#mermaid-container > #mermaid-space > .mermaid-content {
  padding: 2rem;
  position: relative;
  transform-origin: 0 0;
  transition: transform 0.1s ease;
  overflow: visible;
  min-height: 200px;
  min-width: 200px;
}
#mermaid-container > #mermaid-space > .mermaid-content pre {
  margin: 0;
  border: none;
}
#mermaid-container > #mermaid-space > .mermaid-content svg {
  max-width: none;
  height: auto;
}
#mermaid-container > #mermaid-space > .mermaid-controls {
  position: absolute;
  bottom: 20px;
  right: 20px;
  display: flex;
  gap: 8px;
  padding: 8px;
  background: var(--light);
  border: 1px solid var(--lightgray);
  border-radius: 6px;
  box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
  z-index: 2;
}
#mermaid-container > #mermaid-space > .mermaid-controls .mermaid-control-button {
  display: flex;
  align-items: center;
  justify-content: center;
  width: 32px;
  height: 32px;
  padding: 0;
  border: 1px solid var(--lightgray);
  background: var(--light);
  color: var(--dark);
  border-radius: 4px;
  cursor: pointer;
  font-size: 16px;
  font-family: var(--bodyFont);
  transition: all 0.2s ease;
}
#mermaid-container > #mermaid-space > .mermaid-controls .mermaid-control-button:hover {
  background: var(--lightgray);
}
#mermaid-container > #mermaid-space > .mermaid-controls .mermaid-control-button:active {
  transform: translateY(1px);
}
#mermaid-container > #mermaid-space > .mermaid-controls .mermaid-control-button:nth-child(2) {
  width: auto;
  padding: 0 12px;
  font-size: 14px;
}
/*# sourceMappingURL=data:application/json;charset=utf-8;base64,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 */</style><link href="https://cdn.jsdelivr.net/npm/katex@0.16.11/dist/katex.min.css" rel="stylesheet" type="text/css" spa-preserve/><script src="../../../prescript.js" type="application/javascript" spa-preserve></script><script type="application/javascript" spa-preserve>const fetchData = fetch("../../../static/contentIndex.json").then(data => data.json())</script><link rel="alternate" type="application/rss+xml" title="RSS Feed" href="https://glecko.xyz/index.xml"/><meta property="og:image:width" content="1200"/><meta property="og:image:height" content="630"/><meta property="og:image" content="https://glecko.xyz/backbone/core_reviews/summary/08_Schmid_2001_Nature-og-image.webp"/><meta property="og:image:url" content="https://glecko.xyz/backbone/core_reviews/summary/08_Schmid_2001_Nature-og-image.webp"/><meta name="twitter:image" content="https://glecko.xyz/backbone/core_reviews/summary/08_Schmid_2001_Nature-og-image.webp"/><meta property="og:image:type" content="image/.webp"/></head><body data-slug="backbone/core_reviews/summary/08_Schmid_2001_Nature"><div id="quartz-root" class="page"><div id="quartz-body"><div class="left sidebar"><h2 class="page-title"><a href="../../..">Web Of Biocatalysis</a></h2><div class="spacer mobile-only"></div><div style="display: flex; flex-direction: row; flex-wrap: nowrap; gap: 1rem;"><div style="flex-grow: 1; flex-shrink: 1; flex-basis: auto; order: 0; align-self: center; justify-self: center;"><div class="search"><button class="search-button"><p>Search</p><svg role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 19.9 19.7"><title>Search</title><g class="search-path" fill="none"><path stroke-linecap="square" d="M18.5 18.3l-5.4-5.4"></path><circle cx="8" cy="8" r="7"></circle></g></svg></button><div class="search-container"><div class="search-space"><input autocomplete="off" class="search-bar" name="search" type="text" aria-label="Search for something" placeholder="Search for something"/><div class="search-layout" data-preview="true"></div></div></div></div></div><div style="flex-grow: 0; flex-shrink: 1; flex-basis: auto; order: 0; align-self: center; justify-self: center;"><button class="darkmode"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" class="dayIcon" x="0px" y="0px" viewBox="0 0 35 35" style="enable-background:new 0 0 35 35" xml:space="preserve" aria-label="Dark mode"><title>Dark mode</title><path d="M6,17.5C6,16.672,5.328,16,4.5,16h-3C0.672,16,0,16.672,0,17.5    S0.672,19,1.5,19h3C5.328,19,6,18.328,6,17.5z M7.5,26c-0.414,0-0.789,0.168-1.061,0.439l-2,2C4.168,28.711,4,29.086,4,29.5    C4,30.328,4.671,31,5.5,31c0.414,0,0.789-0.168,1.06-0.44l2-2C8.832,28.289,9,27.914,9,27.5C9,26.672,8.329,26,7.5,26z M17.5,6    C18.329,6,19,5.328,19,4.5v-3C19,0.672,18.329,0,17.5,0S16,0.672,16,1.5v3C16,5.328,16.671,6,17.5,6z M27.5,9    c0.414,0,0.789-0.168,1.06-0.439l2-2C30.832,6.289,31,5.914,31,5.5C31,4.672,30.329,4,29.5,4c-0.414,0-0.789,0.168-1.061,0.44    l-2,2C26.168,6.711,26,7.086,26,7.5C26,8.328,26.671,9,27.5,9z M6.439,8.561C6.711,8.832,7.086,9,7.5,9C8.328,9,9,8.328,9,7.5    c0-0.414-0.168-0.789-0.439-1.061l-2-2C6.289,4.168,5.914,4,5.5,4C4.672,4,4,4.672,4,5.5c0,0.414,0.168,0.789,0.439,1.06    L6.439,8.561z M33.5,16h-3c-0.828,0-1.5,0.672-1.5,1.5s0.672,1.5,1.5,1.5h3c0.828,0,1.5-0.672,1.5-1.5S34.328,16,33.5,16z     M28.561,26.439C28.289,26.168,27.914,26,27.5,26c-0.828,0-1.5,0.672-1.5,1.5c0,0.414,0.168,0.789,0.439,1.06l2,2    C28.711,30.832,29.086,31,29.5,31c0.828,0,1.5-0.672,1.5-1.5c0-0.414-0.168-0.789-0.439-1.061L28.561,26.439z M17.5,29    c-0.829,0-1.5,0.672-1.5,1.5v3c0,0.828,0.671,1.5,1.5,1.5s1.5-0.672,1.5-1.5v-3C19,29.672,18.329,29,17.5,29z M17.5,7    C11.71,7,7,11.71,7,17.5S11.71,28,17.5,28S28,23.29,28,17.5S23.29,7,17.5,7z M17.5,25c-4.136,0-7.5-3.364-7.5-7.5    c0-4.136,3.364-7.5,7.5-7.5c4.136,0,7.5,3.364,7.5,7.5C25,21.636,21.636,25,17.5,25z"></path></svg><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" class="nightIcon" x="0px" y="0px" viewBox="0 0 100 100" style="enable-background:new 0 0 100 100" xml:space="preserve" aria-label="Light mode"><title>Light mode</title><path d="M96.76,66.458c-0.853-0.852-2.15-1.064-3.23-0.534c-6.063,2.991-12.858,4.571-19.655,4.571  C62.022,70.495,50.88,65.88,42.5,57.5C29.043,44.043,25.658,23.536,34.076,6.47c0.532-1.08,0.318-2.379-0.534-3.23  c-0.851-0.852-2.15-1.064-3.23-0.534c-4.918,2.427-9.375,5.619-13.246,9.491c-9.447,9.447-14.65,22.008-14.65,35.369  c0,13.36,5.203,25.921,14.65,35.368s22.008,14.65,35.368,14.65c13.361,0,25.921-5.203,35.369-14.65  c3.872-3.871,7.064-8.328,9.491-13.246C97.826,68.608,97.611,67.309,96.76,66.458z"></path></svg></button></div></div><div class="explorer" data-behavior="link" data-collapsed="collapsed" data-savestate="true" data-data-fns="{&quot;order&quot;:[&quot;filter&quot;,&quot;map&quot;,&quot;sort&quot;],&quot;sortFn&quot;:&quot;(a,b)=>!a.isFolder&amp;&amp;!b.isFolder||a.isFolder&amp;&amp;b.isFolder?a.displayName.localeCompare(b.displayName,void 0,{numeric:!0,sensitivity:\&quot;base\&quot;}):!a.isFolder&amp;&amp;b.isFolder?1:-1&quot;,&quot;filterFn&quot;:&quot;node=>node.slugSegment!==\&quot;tags\&quot;&quot;,&quot;mapFn&quot;:&quot;node=>node&quot;}"><button type="button" class="explorer-toggle mobile-explorer hide-until-loaded" data-mobile="true" aria-controls="explorer-content"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide-menu"><line x1="4" x2="20" y1="12" y2="12"></line><line x1="4" x2="20" y1="6" y2="6"></line><line x1="4" x2="20" y1="18" y2="18"></line></svg></button><button type="button" class="title-button explorer-toggle desktop-explorer" data-mobile="false" aria-expanded="true"><h2>Explorer</h2><svg xmlns="http://www.w3.org/2000/svg" width="14" height="14" viewBox="5 8 14 8" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="fold"><polyline points="6 9 12 15 18 9"></polyline></svg></button><div class="explorer-content" aria-expanded="false"><ul class="explorer-ul overflow" id="bnv3ed"><li class="overflow-end"></li></ul></div><template id="template-file"><li><a href="#"></a></li></template><template id="template-folder"><li><div class="folder-container"><svg xmlns="http://www.w3.org/2000/svg" width="12" height="12" viewBox="5 8 14 8" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="folder-icon"><polyline points="6 9 12 15 18 9"></polyline></svg><div><button class="folder-button"><span class="folder-title"></span></button></div></div><div class="folder-outer"><ul class="content"></ul></div></li></template></div></div><div class="center"><div class="page-header"><div class="popover-hint"><nav class="breadcrumb-container" aria-label="breadcrumbs"><div class="breadcrumb-element"><a href="../../../">Home</a><p> ❯ </p></div><div class="breadcrumb-element"><a href="../../../backbone/">backbone</a><p> ❯ </p></div><div class="breadcrumb-element"><a href="../../../backbone/core_reviews/">core_reviews</a><p> ❯ </p></div><div class="breadcrumb-element"><a href="../../../backbone/core_reviews/summary/">summary</a><p> ❯ </p></div><div class="breadcrumb-element"><a href>08_Schmid_2001_Nature</a></div></nav></div></div><article class="popover-hint"><h1 id="industrial-biocatalysis-today-and-tomorrow-schmid-dordick-hauer-kiener-wubbolts-witholt-nature-2001"><em>Industrial biocatalysis today and tomorrow</em> (Schmid, Dordick, Hauer, Kiener, Wubbolts, Witholt, <strong>Nature</strong> 2001)<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#industrial-biocatalysis-today-and-tomorrow-schmid-dordick-hauer-kiener-wubbolts-witholt-nature-2001" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h1>
<p><strong>Citation &amp; scope</strong><br/>
Industry-focused snapshot of <strong>what was already working at scale</strong> (BASF, DSM, Lonza) and a pragmatic framework—“<strong>the biocatalysis cycle</strong>” (from biocatalyst selection → process &amp; DSP → economics)—for taking a reaction to plant. Covers <strong>isolated enzymes vs whole cells</strong>, <strong>non-aqueous &amp; multiphase media</strong>, <strong>gas-phase biocatalysis</strong>, <strong>in-situ product recovery</strong>, and <strong>cofactor recycling</strong> (in vivo &amp; in vitro).</p>
<p><strong>Thesis / what’s new</strong><br/>
Industrial adoption hinges less on “can enzymes do it?” and more on <strong>availability of the right biocatalyst</strong>, <strong>hardware/DS choices kept simple</strong>, and <strong>economics</strong>; with directed evolution + medium/immobilization engineering, biocatalysis competes across <strong>fine chems, APIs, and some bulk</strong>.</p>
<p><strong>Higher-order topic map (authors’ framing)</strong></p>
<ol>
<li>
<p><strong>The biocatalysis cycle</strong> — iterate across <strong>enzyme/cell choice</strong>, <strong>stability</strong>, <strong>cofactor regeneration</strong>, <strong>multiphase media</strong>, <strong>immobilization</strong>, <strong>in-situ recovery</strong>, and <strong>costing</strong>.</p>
</li>
<li>
<p><strong>Media engineering</strong> — organic solvents (incl. <strong>neat</strong> &amp; <strong>scCO₂</strong>), <strong>two-liquid-phase</strong> systems for apolar/toxic substrates, and <strong>gas-phase</strong> biocatalysis; manage toxicity &amp; mass transfer.</p>
</li>
<li>
<p><strong>Formats</strong> — <strong>isolated enzymes</strong> for hydrolysis/isomerization; <strong>whole cells</strong> where cofactors are needed (cheaper recycling, multistep). <strong>Immobilization</strong> standard for reuse.</p>
</li>
<li>
<p><strong>Cofactor strategies</strong> — <strong>in vivo</strong> (cells) and <strong>in vitro</strong> (FDH/GDH; CLEC-based LDH; electrochemical &amp; mediator systems; new <strong>ATP</strong> regeneration with polyphosphate).</p>
</li>
<li>
<p><strong>Downstream &amp; ISR</strong> — precipitation, crystallization, liquid/solid extraction; <strong>phase-split</strong> from organic carriers in 2-phase systems; align DS with reactor choice early.</p>
</li>
<li>
<p><strong>Industrial case blocks</strong> — BASF (lipase resolutions of <strong>alcohols/amines</strong>; nitrilase → <strong>R-mandelic acid</strong>), DSM (amidases → <strong>non-proteinogenic L-AAs</strong>; <strong>aspartame</strong>; <strong>6-APA/7-ADCA</strong> routes), Lonza (N-heterocycles: <strong>ring hydroxylations</strong>, nitrilase + hydroxylase sequences; <strong>nicotine</strong> valorization).</p>
</li>
</ol>
<p><strong>Key exemplars &amp; metrics</strong></p>
<ul>
<li>
<p><strong>Whole-cell two-phase oxidations</strong>: typical activities <strong>100–500 IU·L⁻¹</strong>, sustained <strong>10–20 h</strong>, implying <strong>5–25 t·m⁻³·yr⁻¹</strong> STY for small molecules.</p>
</li>
<li>
<p><strong>Cost model</strong> (n-alkane → alcohol, 10 000 t·yr⁻¹): ~<strong>US<span class="katex"><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height:1em;vertical-align:-0.25em;"></span><span class="mord">8/</span><span class="mord mathnormal" style="margin-right:0.03148em;">k</span><span class="mord mathnormal" style="margin-right:0.03588em;">g</span><span class="mspace" style="margin-right:0.2222em;"></span><span class="mbin">∗</span><span class="mspace" style="margin-right:0.2222em;"></span></span><span class="base"><span class="strut" style="height:0.8889em;vertical-align:-0.1944em;"></span><span class="mord">∗</span><span class="mord mathnormal">p</span><span class="mord mathnormal">ro</span><span class="mord mathnormal">d</span><span class="mord mathnormal">u</span><span class="mord mathnormal">c</span><span class="mord mathnormal">t</span><span class="mpunct">;</span><span class="mspace" style="margin-right:0.1667em;"></span><span class="mord mathnormal" style="margin-right:0.05724em;">maj</span><span class="mord mathnormal">orcos</span><span class="mord mathnormal">t</span><span class="mord mathnormal">s</span><span class="mspace" style="margin-right:0.2778em;"></span><span class="mrel">:</span><span class="mspace" style="margin-right:0.2778em;"></span></span><span class="base"><span class="strut" style="height:1em;vertical-align:-0.25em;"></span><span class="mord mathnormal">m</span><span class="mord mathnormal">e</span><span class="mord mathnormal">d</span><span class="mord mathnormal">ia</span><span class="mopen">(</span><span class="mord mathnormal">c</span><span class="mord mathnormal">a</span><span class="mord mathnormal" style="margin-right:0.02778em;">r</span><span class="mord mathnormal">b</span><span class="mord mathnormal">o</span><span class="mord mathnormal">n</span><span class="mord">/</span><span class="mord mathnormal">s</span><span class="mord mathnormal">a</span><span class="mord mathnormal">lt</span><span class="mord mathnormal">s</span><span class="mclose">)</span><span class="mspace nobreak"> </span><span class="mspace" style="margin-right:0.2222em;"></span><span class="mbin">∗</span><span class="mspace" style="margin-right:0.2222em;"></span></span><span class="base"><span class="strut" style="height:0.6444em;"></span><span class="mord">∗</span><span class="mord">40</span></span></span></span>20–30/kg</strong> (improvements might reach <strong>$5–10/kg</strong>).</p>
</li>
<li>
<p><strong>BASF lipase platforms</strong>: chiral alcohols &amp; amines (vinyl/activated donors) at <strong>hundreds-ton</strong> scale; <strong>nitrilase</strong> to <strong>R-mandelic acid</strong> at <strong>multiton</strong>.</p>
</li>
<li>
<p><strong>DSM</strong>: <strong>amidases</strong> resolve Strecker amide libraries to <strong>L-AAs</strong>; <strong>thermolysin</strong> couples Z-Asp + D/L-Phe-OMe → <strong>aspartame</strong>; <strong>penicillin acylase</strong> for <strong>6-APA</strong> and side-chain couplings.</p>
</li>
<li>
<p><strong>Lonza</strong>: <strong>6-hydroxynicotinic acid</strong> <strong>65 g·L⁻¹</strong>, <strong>~90%</strong> yield; <strong>5-hydroxypyrazinecarboxylic acid</strong> <strong>40 g·L⁻¹</strong>; <strong>(S)-nicotine</strong> → value-added pyridines (up to <strong>30 g·L⁻¹</strong>).</p>
</li>
<li>
<p><strong>In-vitro cofactor</strong>: Degussa <strong>L-tert-leucine</strong> with <strong>FDH/NADH</strong> recycling; <strong>HLADH-CLEC</strong> packed bed: NADH <strong>TTN ≈ 12 000</strong>; electrochemical NAD(P)H regeneration demonstrated.</p>
</li>
</ul>
<p><strong>Limits / gaps (authors’ view)</strong><br/>
Volumetric <strong>O₂ input/heat removal</strong> constrain whole-cell oxygenations at scale; solvent toxicity &amp; mass transfer need <strong>2-phase</strong> engineering; <strong>biocatalyst availability</strong> is often the real gate; regulatory &amp; waste handling still shape choices.</p>
<p><strong>Outlook</strong><br/>
Expect growth wherever <strong>selectivity + DS simplicity</strong> pay: lipases, nitrilases, amidases remain mainstays; <strong>multiphase/gas-phase</strong> and <strong>in-situ recovery</strong> broaden the window; ongoing <strong>evolution/engineering</strong> and <strong>cofactor tech</strong> widen the addressable product value range.</p>
<p><strong>Tags</strong><br/>
Biocatalysis cycle; isolated enzymes vs whole cells; two-phase &amp; gas-phase; immobilization; cofactor (in vivo/in vitro/electrochemical); ISR/DS; cost models; BASF/DSM/Lonza case studies; lipase resolutions; nitrilase; amidase; aspartame; 6-APA/7-ADCA.</p>
<hr/>
<h1 id="biocatalysis-field-topics---from-schmid-et-al-nature-2001">Biocatalysis Field Topics - From Schmid et al. Nature 2001<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#biocatalysis-field-topics---from-schmid-et-al-nature-2001" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h1>
<p><strong>Document ID:</strong> Schmid_2001_Nature</p>
<h2 id="core-topics-extracted">Core Topics Extracted:<a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#core-topics-extracted" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h2>
<h3 id="1-the-biocatalysis-development-cycle">1. <strong>The Biocatalysis Development Cycle</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#1-the-biocatalysis-development-cycle" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Systematic approach to developing industrial biocatalytic processes from product identification to economic implementation</li>
<li><strong>Components</strong>: Biocatalyst selection, process engineering, economic evaluation, and iterative optimization</li>
<li><strong>Application</strong>: Framework for rational development of commercial bioprocesses</li>
</ul>
<h3 id="2-economic-feasibility-analysis">2. <strong>Economic Feasibility Analysis</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#2-economic-feasibility-analysis" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Cost analysis methodology for determining commercial viability of biocatalytic processes</li>
<li><strong>Benchmark</strong>: Products valued >$20-30/kg with >1000 tons/year production and >100 IU/L volumetric activity</li>
<li><strong>Cost Distribution</strong>: Equipment (18-22%), substrates (20%), medium/glucose (40%), energy (10%), waste (5%), personnel (2%)</li>
</ul>
<h3 id="3-two-liquid-phase-biocatalysis">3. <strong>Two-Liquid Phase Biocatalysis</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#3-two-liquid-phase-biocatalysis" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Biotransformation systems using aqueous phase for cells and organic phase for substrates/products</li>
<li><strong>Advantages</strong>: Handles toxic/hydrophobic compounds, enables efficient product recovery, uses established downstream processing</li>
<li><strong>Applications</strong>: Alkane oxidation, aromatic compound transformation, heterocycle modification</li>
</ul>
<h3 id="4-enzyme-catalysis-in-organic-solvents">4. <strong>Enzyme Catalysis in Organic Solvents</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#4-enzyme-catalysis-in-organic-solvents" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Biocatalytic reactions performed in non-aqueous media to overcome water solubility limitations</li>
<li><strong>Benefits</strong>: Higher substrate solubility, reversed hydrolytic reactions, modified enzyme specificity</li>
<li><strong>Activation Methods</strong>: Salt activation (>20,000-fold enhancement), crown ethers, transition-state analogues</li>
</ul>
<h3 id="5-salt-activated-enzyme-systems">5. <strong>Salt-Activated Enzyme Systems</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#5-salt-activated-enzyme-systems" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Dramatic enzyme activation achieved through lyophilization with kosmotropic salts</li>
<li><strong>Mechanism</strong>: Salts stabilize folded enzyme forms during lyophilization and in organic solvents</li>
<li><strong>Performance</strong>: >20,000-fold rate enhancements with subtilisin and other enzymes in organic media</li>
</ul>
<h3 id="6-biocatalytic-plastics-technology">6. <strong>Biocatalytic Plastics Technology</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#6-biocatalytic-plastics-technology" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Incorporation of enzymes into polymeric materials during polymerization to create immobilized biocatalysts</li>
<li><strong>Applications</strong>: Packed-bed reactors, biocatalytic coatings, antifouling surfaces, diagnostic materials</li>
<li><strong>Advantages</strong>: Controlled particle sizes, tailored material properties, enhanced stability</li>
</ul>
<h3 id="7-in-situ-product-recovery-ispr">7. <strong>In Situ Product Recovery (ISPR)</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#7-in-situ-product-recovery-ispr" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Simultaneous product separation during biotransformation to overcome inhibition and improve yields</li>
<li><strong>Methods</strong>: Crystallization, distillation, liquid extraction, adsorption onto solid phases</li>
<li><strong>Benefits</strong>: Overcomes substrate/product inhibition, prevents product decay, enables higher concentrations</li>
</ul>
<h3 id="8-industrial-lipase-applications">8. <strong>Industrial Lipase Applications</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#8-industrial-lipase-applications" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Commercial use of lipases for enantioselective transformations in pharmaceutical and chemical industries</li>
<li><strong>Mechanisms</strong>: Transesterification with vinyl esters/anhydrides for kinetic resolution of alcohols and amines</li>
<li><strong>Scale</strong>: BASF produces hundreds of tons annually of chiral alcohols and amines using lipase processes</li>
</ul>
<h3 id="9-nitrilase-based-industrial-processes">9. <strong>Nitrilase-Based Industrial Processes</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#9-nitrilase-based-industrial-processes" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Commercial production of amino- and hydroxycarboxylic acids through stereoselective nitrile hydrolysis</li>
<li><strong>Strategy</strong>: Integration with existing HCN chemistry to access new chiral intermediates</li>
<li><strong>Example</strong>: BASF’s multiton-scale R-mandelic acid production from racemizing cyanohydrins</li>
</ul>
<h3 id="10-non-proteinogenic-amino-acid-production">10. <strong>Non-Proteinogenic Amino Acid Production</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#10-non-proteinogenic-amino-acid-production" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Industrial synthesis of unnatural amino acids through enzymatic resolution of racemic amides</li>
<li><strong>Technology</strong>: DSM’s amidase toolbox from P. putida, M. neoaurum, O. antropii with varied substrate ranges</li>
<li><strong>Recycling</strong>: Both enantiomers accessible through racemization of undesired isomer</li>
</ul>
<h3 id="11-semisynthetic-antibiotic-manufacturing">11. <strong>Semisynthetic Antibiotic Manufacturing</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#11-semisynthetic-antibiotic-manufacturing" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Green biocatalytic routes for producing β-lactam antibiotics replacing harsh chemical processes</li>
<li><strong>Process</strong>: Penicillin acylase for 6-APA production, enzymatic coupling for semisynthetic derivatives</li>
<li><strong>Advantages</strong>: Mild conditions preserving labile β-lactam rings, eliminating low-temperature chemistry</li>
</ul>
<h3 id="12-n-heterocycle-functionalization">12. <strong>N-Heterocycle Functionalization</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#12-n-heterocycle-functionalization" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Lonza’s biocatalytic routes for selective modification of aromatic N-heterocycles</li>
<li><strong>Applications</strong>: Selective hydroxylation, kinetic resolution, oxidation of methyl groups</li>
<li><strong>Examples</strong>: 6-hydroxynicotinic acid (65 g/L), 5-hydroxypyrazinecarboxylic acid for antituberculosis drugs</li>
</ul>
<h3 id="13-renewable-resource-utilization">13. <strong>Renewable Resource Utilization</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#13-renewable-resource-utilization" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Using natural materials like nicotine from tobacco for pharmaceutical precursor synthesis</li>
<li><strong>Strategy</strong>: Selective functionalization of natural alkaloids to produce drug analogues</li>
<li><strong>Products</strong>: Epibatidine analogues, functionalized pyridines from (S)-nicotine biotransformation</li>
</ul>
<h3 id="14-whole-cell-cofactor-regeneration">14. <strong>Whole-Cell Cofactor Regeneration</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#14-whole-cell-cofactor-regeneration" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Using metabolically active cells for in vivo regeneration of expensive cofactors like NAD(P)H</li>
<li><strong>Advantages</strong>: Eliminates need for external cofactor addition, enables complex multi-enzyme reactions</li>
<li><strong>Applications</strong>: Oxidoreductions, phosphorylated compound synthesis, oligosaccharide production</li>
</ul>
<h3 id="15-steroid-biotransformation-industry">15. <strong>Steroid Biotransformation Industry</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#15-steroid-biotransformation-industry" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Large-scale conversion of plant sterols to pharmaceutical precursors using microbial systems</li>
<li><strong>Scale</strong>: >1000 tons/year worldwide market for androstenedione and androsta-dien-dione</li>
<li><strong>Processes</strong>: Hydroxylations (11α/11β), dehydrogenations, reductions using fungal and bacterial strains</li>
</ul>
<h3 id="16-electrochemical-cofactor-regeneration">16. <strong>Electrochemical Cofactor Regeneration</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#16-electrochemical-cofactor-regeneration" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: In vitro NAD(P)H regeneration using electrical current and mediator compounds</li>
<li><strong>Methods</strong>: Rhodium complexes, mediator proteins, artificial redox mediators</li>
<li><strong>Applications</strong>: Enables isolated enzyme use for oxidoreduction reactions without expensive cofactor consumption</li>
</ul>
<h3 id="17-gas-phase-biocatalysis">17. <strong>Gas-Phase Biocatalysis</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#17-gas-phase-biocatalysis" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Enzyme or cell catalysis with gaseous reactants, avoiding toxic solvents</li>
<li><strong>Advantages</strong>: Simple downstream processing, efficient mass transfer, avoids solvent toxicity</li>
<li><strong>Suitability</strong>: Compounds that can be volatilized at operating conditions</li>
</ul>
<h3 id="18-high-density-cell-cultivation">18. <strong>High-Density Cell Cultivation</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#18-high-density-cell-cultivation" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Achieving 10-40 g/L dry cell mass in two-phase systems for industrial biotransformations</li>
<li><strong>Performance</strong>: 100-500 IU/L volumetric activities, 10-20 hour stability, 5-25 tons/m³/year space-time yields</li>
<li><strong>Host</strong>: E. coli preferred for recombinant systems despite limited solvent resistance</li>
</ul>
<h3 id="19-combinatorial-biocatalysis">19. <strong>Combinatorial Biocatalysis</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#19-combinatorial-biocatalysis" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: High-throughput generation of compound libraries using enzymatic transformations</li>
<li><strong>Applications</strong>: Drug discovery, agrochemicals, biopolymers, nutraceuticals, separation media</li>
<li><strong>Advantages</strong>: Enzyme selectivity enables diverse natural product and synthetic derivatives</li>
</ul>
<h3 id="20-future-biocatalytic-technologies">20. <strong>Future Biocatalytic Technologies</strong><a role="anchor" aria-hidden="true" tabindex="-1" data-no-popover="true" href="#20-future-biocatalytic-technologies" class="internal"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></a></h3>
<ul>
<li><strong>Definition</strong>: Emerging technologies combining miniaturization, automation, and advanced enzyme engineering</li>
<li><strong>Innovations</strong>: Biochips, microfluidic systems, protein-based nanomaterials, directed evolution integration</li>
<li><strong>Potential</strong>: Proteomics applications, functional genomics, automated library screening</li>
</ul>
<hr/>
<p><strong>Review Character</strong>: Comprehensive industrial perspective covering current commercial processes and future technological directions from leading European chemical companies.</p>
<p><strong>Unique Contributions</strong>: Real-world economic analysis, detailed industrial case studies, concrete production scales and costs, technology transfer insights from academic research to industrial implementation.</p>
<p><strong>Key Insights</strong>: Demonstrates that biocatalysis has moved beyond proof-of-concept to large-scale commercial reality, with clear economic drivers and technological enablers for continued growth.</p></article><hr/><div class="page-footer"></div></div><div class="right sidebar"><div class="graph"><h3>Graph View</h3><div class="graph-outer"><div class="graph-container" data-cfg="{&quot;drag&quot;:true,&quot;zoom&quot;:true,&quot;depth&quot;:1,&quot;scale&quot;:1.1,&quot;repelForce&quot;:0.5,&quot;centerForce&quot;:0.3,&quot;linkDistance&quot;:30,&quot;fontSize&quot;:0.6,&quot;opacityScale&quot;:1,&quot;showTags&quot;:true,&quot;removeTags&quot;:[],&quot;focusOnHover&quot;:false,&quot;enableRadial&quot;:false}"></div><button class="global-graph-icon" aria-label="Global Graph"><svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 55 55" fill="currentColor" xml:space="preserve"><path d="M49,0c-3.309,0-6,2.691-6,6c0,1.035,0.263,2.009,0.726,2.86l-9.829,9.829C32.542,17.634,30.846,17,29,17
                s-3.542,0.634-4.898,1.688l-7.669-7.669C16.785,10.424,17,9.74,17,9c0-2.206-1.794-4-4-4S9,6.794,9,9s1.794,4,4,4
                c0.74,0,1.424-0.215,2.019-0.567l7.669,7.669C21.634,21.458,21,23.154,21,25s0.634,3.542,1.688,4.897L10.024,42.562
                C8.958,41.595,7.549,41,6,41c-3.309,0-6,2.691-6,6s2.691,6,6,6s6-2.691,6-6c0-1.035-0.263-2.009-0.726-2.86l12.829-12.829
                c1.106,0.86,2.44,1.436,3.898,1.619v10.16c-2.833,0.478-5,2.942-5,5.91c0,3.309,2.691,6,6,6s6-2.691,6-6c0-2.967-2.167-5.431-5-5.91
                v-10.16c1.458-0.183,2.792-0.759,3.898-1.619l7.669,7.669C41.215,39.576,41,40.26,41,41c0,2.206,1.794,4,4,4s4-1.794,4-4
                s-1.794-4-4-4c-0.74,0-1.424,0.215-2.019,0.567l-7.669-7.669C36.366,28.542,37,26.846,37,25s-0.634-3.542-1.688-4.897l9.665-9.665
                C46.042,11.405,47.451,12,49,12c3.309,0,6-2.691,6-6S52.309,0,49,0z M11,9c0-1.103,0.897-2,2-2s2,0.897,2,2s-0.897,2-2,2
                S11,10.103,11,9z M6,51c-2.206,0-4-1.794-4-4s1.794-4,4-4s4,1.794,4,4S8.206,51,6,51z M33,49c0,2.206-1.794,4-4,4s-4-1.794-4-4
                s1.794-4,4-4S33,46.794,33,49z M29,31c-3.309,0-6-2.691-6-6s2.691-6,6-6s6,2.691,6,6S32.309,31,29,31z M47,41c0,1.103-0.897,2-2,2
                s-2-0.897-2-2s0.897-2,2-2S47,39.897,47,41z M49,10c-2.206,0-4-1.794-4-4s1.794-4,4-4s4,1.794,4,4S51.206,10,49,10z"></path></svg></button></div><div class="global-graph-outer"><div class="global-graph-container" data-cfg="{&quot;drag&quot;:true,&quot;zoom&quot;:true,&quot;depth&quot;:-1,&quot;scale&quot;:0.9,&quot;repelForce&quot;:0.5,&quot;centerForce&quot;:0.2,&quot;linkDistance&quot;:30,&quot;fontSize&quot;:0.6,&quot;opacityScale&quot;:1,&quot;showTags&quot;:true,&quot;removeTags&quot;:[],&quot;focusOnHover&quot;:true,&quot;enableRadial&quot;:true}"></div></div></div><div class="toc desktop-only"><button type="button" class="toc-header" aria-controls="toc-content" aria-expanded="true"><h3>Table of Contents</h3><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="fold"><polyline points="6 9 12 15 18 9"></polyline></svg></button><div class="toc-content"><ul id="kx1zwn" class="overflow"><li class="depth-0"><a href="#industrial-biocatalysis-today-and-tomorrow-schmid-dordick-hauer-kiener-wubbolts-witholt-nature-2001" data-for="industrial-biocatalysis-today-and-tomorrow-schmid-dordick-hauer-kiener-wubbolts-witholt-nature-2001">Industrial biocatalysis today and tomorrow (Schmid, Dordick, Hauer, Kiener, Wubbolts, Witholt, Nature 2001)</a></li><li class="depth-0"><a href="#biocatalysis-field-topics---from-schmid-et-al-nature-2001" data-for="biocatalysis-field-topics---from-schmid-et-al-nature-2001">Biocatalysis Field Topics - From Schmid et al. Nature 2001</a></li><li class="depth-1"><a href="#core-topics-extracted" data-for="core-topics-extracted">Core Topics Extracted:</a></li><li class="depth-2"><a href="#1-the-biocatalysis-development-cycle" data-for="1-the-biocatalysis-development-cycle">1. The Biocatalysis Development Cycle</a></li><li class="depth-2"><a href="#2-economic-feasibility-analysis" data-for="2-economic-feasibility-analysis">2. Economic Feasibility Analysis</a></li><li class="depth-2"><a href="#3-two-liquid-phase-biocatalysis" data-for="3-two-liquid-phase-biocatalysis">3. Two-Liquid Phase Biocatalysis</a></li><li class="depth-2"><a href="#4-enzyme-catalysis-in-organic-solvents" data-for="4-enzyme-catalysis-in-organic-solvents">4. Enzyme Catalysis in Organic Solvents</a></li><li class="depth-2"><a href="#5-salt-activated-enzyme-systems" data-for="5-salt-activated-enzyme-systems">5. Salt-Activated Enzyme Systems</a></li><li class="depth-2"><a href="#6-biocatalytic-plastics-technology" data-for="6-biocatalytic-plastics-technology">6. Biocatalytic Plastics Technology</a></li><li class="depth-2"><a href="#7-in-situ-product-recovery-ispr" data-for="7-in-situ-product-recovery-ispr">7. In Situ Product Recovery (ISPR)</a></li><li class="depth-2"><a href="#8-industrial-lipase-applications" data-for="8-industrial-lipase-applications">8. Industrial Lipase Applications</a></li><li class="depth-2"><a href="#9-nitrilase-based-industrial-processes" data-for="9-nitrilase-based-industrial-processes">9. Nitrilase-Based Industrial Processes</a></li><li class="depth-2"><a href="#10-non-proteinogenic-amino-acid-production" data-for="10-non-proteinogenic-amino-acid-production">10. Non-Proteinogenic Amino Acid Production</a></li><li class="depth-2"><a href="#11-semisynthetic-antibiotic-manufacturing" data-for="11-semisynthetic-antibiotic-manufacturing">11. Semisynthetic Antibiotic Manufacturing</a></li><li class="depth-2"><a href="#12-n-heterocycle-functionalization" data-for="12-n-heterocycle-functionalization">12. N-Heterocycle Functionalization</a></li><li class="depth-2"><a href="#13-renewable-resource-utilization" data-for="13-renewable-resource-utilization">13. Renewable Resource Utilization</a></li><li class="depth-2"><a href="#14-whole-cell-cofactor-regeneration" data-for="14-whole-cell-cofactor-regeneration">14. Whole-Cell Cofactor Regeneration</a></li><li class="depth-2"><a href="#15-steroid-biotransformation-industry" data-for="15-steroid-biotransformation-industry">15. Steroid Biotransformation Industry</a></li><li class="depth-2"><a href="#16-electrochemical-cofactor-regeneration" data-for="16-electrochemical-cofactor-regeneration">16. Electrochemical Cofactor Regeneration</a></li><li class="depth-2"><a href="#17-gas-phase-biocatalysis" data-for="17-gas-phase-biocatalysis">17. Gas-Phase Biocatalysis</a></li><li class="depth-2"><a href="#18-high-density-cell-cultivation" data-for="18-high-density-cell-cultivation">18. High-Density Cell Cultivation</a></li><li class="depth-2"><a href="#19-combinatorial-biocatalysis" data-for="19-combinatorial-biocatalysis">19. Combinatorial Biocatalysis</a></li><li class="depth-2"><a href="#20-future-biocatalytic-technologies" data-for="20-future-biocatalytic-technologies">20. Future Biocatalytic Technologies</a></li><li class="overflow-end"></li></ul></div></div></div><footer class><p>Created with <a href="https://quartz.jzhao.xyz/">Quartz v4.5.0</a> © 2026</p><ul></ul></footer></div></div></body><script type="application/javascript">function o(){let t=this.parentElement;t.classList.toggle("is-collapsed");let e=t.classList.contains("is-collapsed")?this.scrollHeight:t.scrollHeight;t.style.maxHeight=e+"px";let c=t,l=t.parentElement;for(;l;){if(!l.classList.contains("callout"))return;let i=l.classList.contains("is-collapsed")?l.scrollHeight:l.scrollHeight+c.scrollHeight;l.style.maxHeight=i+"px",c=l,l=l.parentElement}}function n(){let t=document.getElementsByClassName("callout is-collapsible");for(let s of t){let e=s.firstElementChild;if(!e)continue;e.addEventListener("click",o),window.addCleanup(()=>e.removeEventListener("click",o));let l=s.classList.contains("is-collapsed")?e.scrollHeight:s.scrollHeight;s.style.maxHeight=l+"px"}}document.addEventListener("nav",n);
</script><script type="module">function f(i,e){if(!i)return;function r(o){o.target===this&&(o.preventDefault(),o.stopPropagation(),e())}function t(o){o.key.startsWith("Esc")&&(o.preventDefault(),e())}i?.addEventListener("click",r),window.addCleanup(()=>i?.removeEventListener("click",r)),document.addEventListener("keydown",t),window.addCleanup(()=>document.removeEventListener("keydown",t))}function y(i){for(;i.firstChild;)i.removeChild(i.firstChild)}var h=class{constructor(e,r){this.container=e;this.content=r;this.setupEventListeners(),this.setupNavigationControls(),this.resetTransform()}isDragging=!1;startPan={x:0,y:0};currentPan={x:0,y:0};scale=1;MIN_SCALE=.5;MAX_SCALE=3;cleanups=[];setupEventListeners(){let e=this.onMouseDown.bind(this),r=this.onMouseMove.bind(this),t=this.onMouseUp.bind(this),o=this.resetTransform.bind(this);this.container.addEventListener("mousedown",e),document.addEventListener("mousemove",r),document.addEventListener("mouseup",t),window.addEventListener("resize",o),this.cleanups.push(()=>this.container.removeEventListener("mousedown",e),()=>document.removeEventListener("mousemove",r),()=>document.removeEventListener("mouseup",t),()=>window.removeEventListener("resize",o))}cleanup(){for(let e of this.cleanups)e()}setupNavigationControls(){let e=document.createElement("div");e.className="mermaid-controls";let r=this.createButton("+",()=>this.zoom(.1)),t=this.createButton("-",()=>this.zoom(-.1)),o=this.createButton("Reset",()=>this.resetTransform());e.appendChild(t),e.appendChild(o),e.appendChild(r),this.container.appendChild(e)}createButton(e,r){let t=document.createElement("button");return t.textContent=e,t.className="mermaid-control-button",t.addEventListener("click",r),window.addCleanup(()=>t.removeEventListener("click",r)),t}onMouseDown(e){e.button===0&&(this.isDragging=!0,this.startPan={x:e.clientX-this.currentPan.x,y:e.clientY-this.currentPan.y},this.container.style.cursor="grabbing")}onMouseMove(e){this.isDragging&&(e.preventDefault(),this.currentPan={x:e.clientX-this.startPan.x,y:e.clientY-this.startPan.y},this.updateTransform())}onMouseUp(){this.isDragging=!1,this.container.style.cursor="grab"}zoom(e){let r=Math.min(Math.max(this.scale+e,this.MIN_SCALE),this.MAX_SCALE),t=this.content.getBoundingClientRect(),o=t.width/2,n=t.height/2,c=r-this.scale;this.currentPan.x-=o*c,this.currentPan.y-=n*c,this.scale=r,this.updateTransform()}updateTransform(){this.content.style.transform=`translate(${this.currentPan.x}px, ${this.currentPan.y}px) scale(${this.scale})`}resetTransform(){this.scale=1;let e=this.content.querySelector("svg");this.currentPan={x:e.getBoundingClientRect().width/2,y:e.getBoundingClientRect().height/2},this.updateTransform()}},C=["--secondary","--tertiary","--gray","--light","--lightgray","--highlight","--dark","--darkgray","--codeFont"],E;document.addEventListener("nav",async()=>{let e=document.querySelector(".center").querySelectorAll("code.mermaid");if(e.length===0)return;E||=await import("https://cdnjs.cloudflare.com/ajax/libs/mermaid/11.4.0/mermaid.esm.min.mjs");let r=E.default,t=new WeakMap;for(let n of e)t.set(n,n.innerText);async function o(){for(let s of e){s.removeAttribute("data-processed");let a=t.get(s);a&&(s.innerHTML=a)}let n=C.reduce((s,a)=>(s[a]=window.getComputedStyle(document.documentElement).getPropertyValue(a),s),{}),c=document.documentElement.getAttribute("saved-theme")==="dark";r.initialize({startOnLoad:!1,securityLevel:"loose",theme:c?"dark":"base",themeVariables:{fontFamily:n["--codeFont"],primaryColor:n["--light"],primaryTextColor:n["--darkgray"],primaryBorderColor:n["--tertiary"],lineColor:n["--darkgray"],secondaryColor:n["--secondary"],tertiaryColor:n["--tertiary"],clusterBkg:n["--light"],edgeLabelBackground:n["--highlight"]}}),await r.run({nodes:e})}await o(),document.addEventListener("themechange",o),window.addCleanup(()=>document.removeEventListener("themechange",o));for(let n=0;n<e.length;n++){let v=function(){let g=l.querySelector("#mermaid-space"),m=l.querySelector(".mermaid-content");if(!m)return;y(m);let w=c.querySelector("svg").cloneNode(!0);m.appendChild(w),l.classList.add("active"),g.style.cursor="grab",u=new h(g,m)},M=function(){l.classList.remove("active"),u?.cleanup(),u=null},c=e[n],s=c.parentElement,a=s.querySelector(".clipboard-button"),d=s.querySelector(".expand-button"),p=window.getComputedStyle(a),L=a.offsetWidth+parseFloat(p.marginLeft||"0")+parseFloat(p.marginRight||"0");d.style.right=`calc(${L}px + 0.3rem)`,s.prepend(d);let l=s.querySelector("#mermaid-container");if(!l)return;let u=null;d.addEventListener("click",v),f(l,M),window.addCleanup(()=>{u?.cleanup(),d.removeEventListener("click",v)})}});
</script><script src="https://cdn.jsdelivr.net/npm/katex@0.16.11/dist/contrib/copy-tex.min.js" type="application/javascript"></script><script src="../../../postscript.js" type="module"></script></html>